| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $26.6M | -30.0% |
| Cost of Revenue | $39.4M | -10.0% |
| R&D Expense | $41.7M | -22.8% |
| SG&A Expense | $97.6M | -11.5% |
| Operating Income | -$110.4M | +4.9% |
| Pre-tax Income | -$93.9M | +14.2% |
| Income Tax | $43K | -44.9% |
| Net Income | -$93.9M | +14.3% |
| EPS (Basic) | -$0.46 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $64.4M | -61.6% |
| Inventory | $26.9M | -16.1% |
| Current Assets | $98.4M | -53.3% |
| Total Assets | $148.0M | -44.4% |
| Current Liabilities | $29.9M | -35.5% |
| Total Liabilities | $32.8M | -45.5% |
| Stockholders' Equity | $115.1M | -44.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$93.9M | -12.5% |
| Capital Expenditures | $8.1M | -40.1% |
| Investing Cash Flow | -$8.1M | +40.1% |
| Financing Cash Flow | -$1.4M | -250.5% |
| Free Cash Flow | -$101.9M | -5.2% |
| +14.8% |
| EPS (Diluted) | -$0.46 | +14.8% |